Current Treatment Strategies and Risk Stratification for Oral Carcinoma.

Management of oral cavity squamous cell carcinoma (OSCC) involves a multidisciplinary team approach. Surgery is ideally the primary treatment option for nonmetastatic OSCC, and less invasive curative surgical approaches are preferred in early-stage disease to minimize surgical-related morbidity. For patients at high risk of recurrence, adjuvant treatment using radiation therapy or chemoradiation is often used. Systemic therapy may also be used in the neoadjuvant setting (for advanced-stage disease with the intent of mandibular preservation) or in the palliative setting (for nonsalvageable locoregional recurrence and/or distant metastases). Patient involvement in treatment decision is the key for patient-driven management, particularly in clinical situation with poor prognosis, for example, early postoperative recurrence before planned adjuvant therapy.

• Publication year

  2023

• Venue

  American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

• Publication date

  2023-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/EDBK_389810PMID 37200591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral Squamous Cell Carcinoma and Concomitant Primary Tumors, What Do We Know? A Review of the Literature

  2023cited by this paper
• Modifiable risk factors for oral cavity cancer in non-smokers: A systematic review and meta-analysis.

  2023cited by this paper
• Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial

  2022cited by this paper
• Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design.

  2022cited by this paper
• Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity.

  2022cited by this paper
• LBA5 Primary results of the phase III KEYNOTE-412 study: Pembrolizumab (pembro) with chemoradiation therapy (CRT) vs placebo plus CRT for locally advanced (LA) head and neck squamous cell carcinoma (HNSCC)

  2022cited by this paper
• Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost

  2021cited by this paper
• Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

  2021cited by this paper
• LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial

  2021cited by this paper
• Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer

  2021cited by this paper
• Serial step sections at narrow intervals with immunohistochemistry are required for accurate histological assessment of sentinel lymph node biopsy in oral squamous cell carcinoma

  2021cited by this paper
• Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial.

  2020cited by this paper
• Learning curve for sentinel lymph node mapping in gynecologic malignancies

  2020cited by this paper
• Nonsurgical management of resectable oral cavity cancer in the wake of COVID-19: A rapid review and meta-analysis

  2020cited by this paper
• Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial.

  2020cited by this paper
• Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal Cancer.

  2020cited by this paper
• Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach

  2020cited by this paper
• Validation of distant metastases risk-groups in oral cavity squamous cell carcinoma patients treated with postoperative intensity-modulated radiotherapy.

  2019cited by this paper
• Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer

  2019cited by this paper
• Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice

  2019cited by this paper
• Elective neck dissection in oral squamous cell carcinoma: Past, present and future.

  2019cited by this paper
• Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher.

  2019cited by this paper
• Predictors of Early Recurrence Prior to Planned Postoperative Radiation Therapy for Oral Cavity Squamous Cell Carcinoma and Outcomes Following Salvage Intensified Radiation Therapy.

  2019cited by this paper
• Evaluation of quality of life in patients with oral cancer after mandibular resection

  2019cited by this paper
• Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.

  2019cited by this paper
• Laryngeal Preservation Strategies in Locally Advanced Laryngeal and Hypopharyngeal Cancers

  2019cited by this paper
• Sentinel lymph node biopsy for management of the N0 neck in oral cavity squamous cell carcinoma

  2019cited by this paper
• Sentinel node biopsy in early oral squamous cell carcinomas: Long-term follow-up and nodal failure analysis.

  2018cited by this paper
• National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival

  2018cited by this paper
• Factors Affecting Survival in Surgically Salvaged Locoregional Recurrences of Squamous Cell Carcinoma of the Tongue.

  2018cited by this paper
• Neck recurrence in clinically node-negative oral cancer: 27-year experience at a single institution.

  2018cited by this paper
• Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience.

  2018cited by this paper
• Efficacy of postoperative neck irradiation for regional control in patients with pN0 oral tongue cancer: Propensity analysis

  2018cited by this paper
• Preoperative assessment of CD44‐mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma

  2018cited by this paper
• Efficacy of Carboplatin/Paclitaxel-Based Radiochemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck

  2018cited by this paper
• Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Stage I to II Oral Cavity Cancer

  2018cited by this paper
• Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.

  2017cited by this paper
• Sentinel lymph node biopsy for early oral cancers: Westmead Hospital experience

  2017cited by this paper
• Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.

  2017cited by this paper
• Distant Metastases Following Postoperative Intensity-Modulated Radiotherapy for Oral Cavity Squamous Cell Carcinoma

  2017cited by this paper
• A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.

  2017cited by this paper
• Sentinel node biopsy versus elective neck dissection. Which is more cost-effective? A prospective observational study.

  2016cited by this paper
• Sentinel Node in Oral Cancer: The Nuclear Medicine Aspects. A Survey from the Sentinel European Node Trial

  2016cited by this paper
• Staging of early lymph node metastases with the sentinel lymph node technique and predictive factors in T1/T2 oral cavity cancer: A retrospective single‐center study

  2016cited by this paper
• Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinoma

  2016cited by this paper
• Risk factors of distant metastasis in patients with squamous cell carcinoma of the oral cavity.

  2016cited by this paper
• Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

  2016cited by this paper
• Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review.

  2016cited by this paper
• Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer.

  2015cited by this paper
• Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.

  2015cited by this paper
• Neoadjuvant chemotherapy and surgical margin in technically unresectable buccal mucosa cancers.

  2015cited by this paper
• Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta‐analysis

  2015cited by this paper
• Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

  2014cited by this paper
• Health-related quality of life after mandibular resection for oral cancer: Reconstruction with free fibula flap

  2014cited by this paper
• Role of high dose rate interstitial brachytherapy in early and locally advanced squamous cell carcinoma of buccal mucosa

  2014cited by this paper
• Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.

  2014cited by this paper
• Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial.

  2014cited by this paper
• Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis

  2013cited by this paper
• Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?

  2013cited by this paper
• Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.

  2013cited by this paper
• Primary chemoradiotherapy for oral cavity squamous cell carcinoma.

  2012cited by this paper
• Posttreatment CT and MR imaging in head and neck cancer: what the radiologist needs to know.

  2012cited by this paper
• Sentinel Lymph Node Biopsy for T1/T2 Oral Cavity Squamous Cell Carcinoma—A Prospective Case Series

  2012cited by this paper
• Quality of life in oral cancer patients--effects of mandible resection and socio-cultural aspects.

  2012cited by this paper
• Sentinel Lymph Node Biopsy for T1/T2 Oral Cavity Squamous Cell Carcinoma—A Prospective Case Series

  2011cited by this paper
• Primary tumor site as a predictor of treatment outcome for definitive radiotherapy of advanced-stage oral cavity cancers.

  2010cited by this paper
• Sentinel Node Biopsy in Head and Neck Squamous Cell Cancer: 5-Year Follow-Up of a European Multicenter Trial

  2010cited by this paper
• Analysis of prognostic factors in 1180 patients with oral cavity primary cancer treated with definitive or adjuvant radiotherapy.

  2010cited by this paper
• Predicting the prognosis of oral squamous cell carcinoma after first recurrence.

  2010cited by this paper
• Anesthetic Complications Associated with Pediatric Cochlear Implantation

  2010cited by this paper
• Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial.

  2010cited by this paper
• Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy

  2009cited by this paper
• CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck

  2009cited by this paper
• Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.

  2008cited by this paper
• Long‐Term Results of a Phase III Randomized Trial of Postoperative Radiotherapy With or Without Carboplatin in Patients With High‐Risk Head and Neck Cancer

  2008cited by this paper
• Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

  2007cited by this paper
• Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

  2007cited by this paper
• Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.

  2006cited by this paper
• Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

  2006cited by this paper
• Risk factors for distant metastases in head and neck squamous cell carcinoma.

  2006cited by this paper
• Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

  2005cited by this paper
• The Second International Conference on Sentinel Node Biopsy in Mucosal Head and Neck Cancer

  2005cited by this paper
• Retromolar trigone carcinoma treated by primary radiation therapy: an alternative to the primary surgical approach.

  2005cited by this paper
• Sentinel lymph node detection in patients with endometrial cancer.

  2004cited by this paper
• Sentinel Node Biopsy in Head and Neck Cancer: Preliminary Results of a Multicenter Trial

  2004cited by this paper
• Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time.

  2003cited by this paper
• A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

  2003cited by this paper
• Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.

  2003cited by this paper
• Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.

  2003cited by this paper
• Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer.

  2002cited by this paper
• Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation

  2002cited by this paper
• Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck

  2002cited by this paper
• Distant Metastases from Lip and Oral Cavity Cancer

  2001cited by this paper
• Head and neck squamous cell carcinoma: US-guided fine-needle aspiration of sentinel lymph nodes for improved staging--initial experience.

  2001cited by this paper
• Sentinel Lymph Node Biopsy for Melanoma: How Many Radioactive Nodes Should be Removed?

  2001cited by this paper
• Sentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program Experience

  2000cited by this paper
• Reliability of sentinel lymph node biopsy for staging melanoma

  2000cited by this paper
• Imaging-based nodal classification for evaluation of neck metastatic adenopathy.

  2000cited by this paper

• Impact of postoperative radiotherapy and chemoradiotherapy on survival outcomes in oral squamous cell carcinoma patients with pN1 neck disease

  2026cites this paper
• ZDBF2/SIRT6-mediated H3K27 deacetylation inhibits ferroptosis and reduces sensitivity of oral squamous cell carcinoma to cisplatin.

  2026cites this paper
• Sentinel Lymph‐Node Biopsy Guided Neck Dissection Versus Elective Neck Dissection in the Management of Early‐Stage Oral Cancer—A Cost‐Utility Analysis

  2026cites this paper
• The emerging role of neoadjuvant immunotherapy in locally advanced oral squamous cell carcinoma: progress and challenges.

  2026cites this paper
• Therapeutic gases as emerging treatments for oral diseases.

  2026cites this paper
• Chemoradiotherapy Increases the Incidence Rate of Cachexia in Head and Neck Cancer: A Cohort Study.

  2025cites this paper
• Palliative care with ayurveda in squamous cell carcinoma of tongue – A case report

  2025cites this paper
• ELLAGIC ACID IN POMEGRANATE SEEDS AS A POTENTIAL THERAPEUTIC FOR ORAL CANCER VIA THE PI3K/AKT PATHWAY: AN IN SILICO

  2025cites this paper
• Dopamine and Mn(II) Chelate Covalent-Doping Coated Ti(IV)-Nanotheranostics for Magnetic Resonance Imaging Guided Phototherapy in Oral Cancer

  2025cites this paper
• Organoid morphology-guided classification for oral cancer reveals prognosis

  2025cites this paper
• Emerging Role of Lenvatinib in Treating Platinum-Refractory Head and Neck Cancer in Resource-Limited Settings

  2025cites this paper
• Tumor control and survival after postoperative radiotherapy for high-risk oral cavity cancer: A retrospective cohort study

  2025cites this paper
• Pragmatic patient choice-driven radical treatment approach (PRAGRAD) for very advanced Unresectable Oral Cavity Cancers.

  2025cites this paper
• Adjuvant Radiotherapy for Early‐Stage Oral Tongue Cancer: Insights From the NCDB Based on Grade

  2025cites this paper
• Effects of Maackia amurensis seed lectin (MASL) on OSCC cell morphology, PDPN expression, growth, and motility in a phase 1 clinical trial

  2025cites this paper
• Clinicopathologic Predictors of Survival Following Oral Cancer Surgery: A Retrospective Cohort Study

  2025cites this paper
• Prognostic impact of immune phenotype in oral squamous cell carcinoma.

  2025cites this paper
• Oral squamous cell carcinoma pharmacological treatment; A long non-coding RNAs (long ncRNAs) story

  2025cites this paper
• NAMS task force report on oral cancer

  2025cites this paper
• Preferences and utilities for the health states in the treatment of neck in oral cancers

  2025cites this paper
• Unravelling molecular mechanism of oral squamous cell carcinoma and genetic landscape: an insight into disease complexity, available therapies, and future considerations

  2025cites this paper
• Generation and Characterization of Cisplatin-Resistant Oral Squamous Cell Carcinoma Cells Displaying an Epithelial–Mesenchymal Transition Signature

  2025cites this paper
• Radiotherapy and Its Consequences in Relation to Oral Squamous Cell Carcinoma—A Narrative Review

  2025cites this paper
• In vitro determination of patient-specific variation challenges the universal RBE gold standard for proton radiation therapy

  2025cites this paper
• In-silico and In-vitro Gene Expression Analysis on Docetaxel and Methotrexate-induced Cytotoxicity in Oral Cancer Cell Line.

  2025cites this paper
• Recent knowledge on squamous cell carcinoma of the oral cavity: Contributing factors, underlying molecular pathways, and current attitudes in the therapeutic approaches

  2025cites this paper
• Impact of Margin Assessment Method on Adjuvant Therapy and Recurrence in Early Oral Cancer

  2025cites this paper
• Early Oral Cancer Detection with AI: Design and Implementation of a Deep Learning Image-Based Chatbot

  2025cites this paper
• Integrative analysis of spatiotemporal transcriptomics delineates dynamic cell states in squamous tumorigenesis

  2025cites this paper
• Impact of the COVID-19 Pandemic on Pathological Stage, Tumor Characteristics and Surgical Outcomes of Oral Squamous Cell Carcinoma: A Retrospective Analysis

  2025cites this paper
• Current and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer

  2025cites this paper
• Expression and functional role of LncRNA GSEC in oral squamous cell carcinoma

  2025cites this paper
• The PTTG1/VASP axis promotes oral squamous cell carcinoma metastasis by modulating focal adhesion and actin filaments

  2025cites this paper
• Application of MMP-2-responsive in situ forming injectable hydrogel in preventing the recurrence of oral squamous cell carcinoma

  2025cites this paper
• FAMM flap in oral cavity and tongue defect reconstruction: A systematic review and meta-analysis.

  2025cites this paper
• Pro-inflammatory Mediator and Cancer-Associated Chemokine CXCL8 as a Prognostic Indicator of Tumor Aggressiveness, Angiogenesis, and Disease Progression with Focus on Therapeutic Implications and Recurrence Monitoring

  2025cites this paper
• Unveiling the Therapeutic Potential of Soft Plasma Jet and Nitric-Oxide Enriched Plasma-Activated Water (NO-PAW) on Oral Cancer YD-10B Cells: A Comprehensive Investigation of Direct and Indirect Treatments

  2025cites this paper
• Comparison of Quality of Life in Tongue Cancer Patients Following Various Glossectomy Reconstructive Techniques.

  2025cites this paper
• The miR-876-5p/SOCS4/STAT3 pathway induced the expression of PD-L1 and suppressed antitumor immune responses

  2025cites this paper
• Custom lingual augmentation prostheses for a patient with dysarthria, dysphagia, and functional deficits following complete glossectomy: A clinical report.

  2025cites this paper
• Chemotherapy-free innovations in locally advanced head and neck cancer: a comprehensive review

  2025cites this paper
• Targeting Oral Squamous Cell Carcinoma with Combined Polo-Like-Kinase-1 Inhibitors and γ-Radiation Therapy

  2024cites this paper
• HOXC6‐mediated transcriptional activation of ENO2 promotes oral squamous cell carcinoma progression through the Warburg effect

  2024cites this paper
• Imaging Biomarkers of Oral Dysplasia and Carcinoma Measured with In Vivo Endoscopic Optical Coherence Tomography

  2024cites this paper
• Adjunctive Impact of Mitochondria-Targeting Antibiotics for Cancer Stem Cells of Oral Squamous Cell Carcinoma: Proposal for a Novel Approach in Resistant Cases

  2024cites this paper
• Unveiling the nexus: Long non-coding RNAs and the PI3K/Akt pathway in oral squamous cell carcinoma.

  2024cites this paper
• Lactiplantibacillus plantarum exerts anticancer effects and increase the chemosensitivity of 5-fluorouracil against oral cancer cells in vitro

  2024cites this paper
• A novel non-coding m6A reader RBFOX2 expression is increased in oral squamous cell carcinoma and promotes tumorigenesis.

  2024cites this paper
• Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer

  2024cites this paper
• Tumour Budding in Oral Squamous Cell Carcinoma: A Narrative Review

  2024cites this paper
• Microvascular Reconstructions in Elderly Patients With Oral Squamous Cell Carcinoma - Too Old for Surgical Treatment?

  2024cites this paper
• High TNF and NF-κB Pathway Dependency Are Associated with AZD5582 Sensitivity in OSCC via CASP8-Dependent Apoptosis

  2024cites this paper
• Validation of clinical tumor depth of invasion measure in patients with oral cavity cancer

  2024cites this paper
• Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers

  2024cites this paper
• Clinical outcomes and impact of prognostic factors in resectable oral cavity squamous cell carcinoma

  2024cites this paper
• Molecular Targets of Plant-Derived Bioactive Compounds in Oral Squamous Cell Carcinoma

  2024cites this paper
• Targeting mitochondrial dynamics: an in-silico approach for repurposing antifungal drugs in OSCC treatment

  2024cites this paper
• Impact of the International Tumor Budding Consensus Conference Recommendations in Oral Cancer

  2024cites this paper
• Long-Term Survival after Stereotactic Radiotherapy Combined with Immunotherapy in a Patient with Recurrent Oral Cancer

  2024cites this paper
• DNA hypermethylation of tumor suppressor genes among oral squamous cell carcinoma patients: a prominent diagnostic biomarker

  2024cites this paper
• Dichloroacetate and chloroquine in combination with arsenite suppress ROS-induced oral squamous cell carcinoma (OSCC) development and improve BALB/c mice survival.

  2024cites this paper
• Treatment Complications of Head and Neck Cancers and Rehabilitation Measures: A Narrative Review

  2024cites this paper
• Heavy metal exposure as a risk factor in oral cancer

  2024cites this paper
• A Phase I/II study evaluating the feasibility and safety of delivering adjuvant Hypofractionated radiotherapy in resected oral cavity cancers (HYPO-ART study)

  2024cites this paper
• Addition of tumor microenvironment immune cell composition to improve the performance of a predictive model for oral squamous cell carcinoma.

  2024cites this paper
• Oncologic Outcomes of Salvage Surgery in Recurrent Oral Tongue Squamous Cell Carcinoma

  2024cites this paper
• Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review

  2023cites this paper